In our experience, peptide therapy allows us to target the root cause of slow healingwhether its inflammation, poor circulation, or cellular inefficiency
BPC-157 is not approved for human use by the MHRA, EMA, or FDA and has no marketing authorisation in the UK
Versatile Application Methods peptide therapy can be taken orally (best for gut and organ healing) or injected subcutaneously or intramuscularly (best for musculoskeletal repair)
For the science on individual compounds, see our evidence-based peptide guide
BPC-157: Growth Factor Upregulation On the growth factor side, BPC-157 cranks up VEGF, EGF, and TGF-beta the signals that tell your body to build new blood vessels at the injury
The only way it might be done is if a group of researchers could convince a non-profit organisation to provide a grant